Dental insurance might not cover this advanced oral cancer screening as an addition to the standard visual examination. This practice prescribes the ViziLite Plus exam for all patients at increased risk but especially those at high risk and highest risk for oral cancer. We will be performing the Vizilite Plus exam following the standard oral cancer examination of the oral cavity for a fee.
Relative oral cancer risk by patient profile:
Highest Risk: Patients age 40 and older and lifestyle risk factors (tobacco)
Patients with a history of oral cancer
High Risk: Patients age 40 and older; tobacco users of any age
Increased Risk: Patients age 18-39
Highest Risk: Patients age 40 and older and lifestyle risk factors (tobacco)
Patients with a history of oral cancer
High Risk: Patients age 40 and older; tobacco users of any age
Increased Risk: Patients age 18-39
In our continuing efforts to provide the most advanced technology and highest quality care available to our patients, Dental Love, LLC is proud to announce the inclusion of the ViziLite Plus exam as an integral part of our annual comprehensive oral cancer screening program.
One person dies every hour from oral cancer in the United States- and the mortality has remained unchanged for more than 40 years. Alarmingly, more than 25% of oral cancer victims have no lifestyle risk factors (tobacco use). Clinical studies have determined that using ViziLite after the standard oral cancer examination improves the clinician’s ability to identify lesions suspicious for pathology. Early detection of pre-cancerous tissue can minimize or eliminate the potentially disfiguring effects of oral cancer. Proven screening technologies such as mammogram, Pap smear, PSA and colonoscopy offer the same types of early detection of cancer. ViziLite Plus is an easy and painless examination that gives Dental Love, LLC the best chance to find any oral abnormalities you may have at the earliest possible stage. This technology is the only medical devise cleared by the FDA for the identification and monitoring of oral abnormalities in populations at increased risk for oral cancer.
One person dies every hour from oral cancer in the United States- and the mortality has remained unchanged for more than 40 years. Alarmingly, more than 25% of oral cancer victims have no lifestyle risk factors (tobacco use). Clinical studies have determined that using ViziLite after the standard oral cancer examination improves the clinician’s ability to identify lesions suspicious for pathology. Early detection of pre-cancerous tissue can minimize or eliminate the potentially disfiguring effects of oral cancer. Proven screening technologies such as mammogram, Pap smear, PSA and colonoscopy offer the same types of early detection of cancer. ViziLite Plus is an easy and painless examination that gives Dental Love, LLC the best chance to find any oral abnormalities you may have at the earliest possible stage. This technology is the only medical devise cleared by the FDA for the identification and monitoring of oral abnormalities in populations at increased risk for oral cancer.
